BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27623695)

  • 21. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS; Rivard MJ
    Med Phys; 2006 Jun; 33(6):1729-37. PubMed ID: 16872080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
    Ballester F; Granero D; Pérez-Calatayud J; Casal E; Puchades V
    Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermoluminescent and Monte Carlo dosimetry of a new 170Tm brachytherapy source.
    Nazari S; Sadeghi M; Shirvani-Arani S; Bahrami-Samani A; Saidi P
    Phys Med; 2014 Mar; 30(2):178-83. PubMed ID: 23764298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of dosimetric functions for a new
    Safaeipour E; Poorbaygi H; Jabbari I; Sheibani S
    J Appl Clin Med Phys; 2021 Sep; 22(9):82-93. PubMed ID: 34263515
    [No Abstract]   [Full Text] [Related]  

  • 26. Dosimetry of 192Ir wires for LDR interstitial brachytherapy following the AAPM TG-43 dosimetric formalism.
    Karaiskos P; Papagiannis P; Angelopoulos A; Sakelliou L; Baltas D; Sandilos P; Vlachos L
    Med Phys; 2001 Feb; 28(2):156-66. PubMed ID: 11243338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric and radiobiological comparison of TG-43 and Monte Carlo calculations in
    Peppa V; Pappas EP; Karaiskos P; Major T; Polgár C; Papagiannis P
    Phys Med; 2016 Oct; 32(10):1245-1251. PubMed ID: 27720277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monte Carlo characterization of high atomic number inorganic scintillators for in vivo dosimetry in
    Kaveckyte V; Jørgensen EB; Kertzscher G; Johansen JG; Carlsson Tedgren Å
    Med Phys; 2022 Jul; 49(7):4715-4730. PubMed ID: 35443079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monte Carlo study of TG-43 dosimetry parameters of GammaMed Plus high dose rate
    Wu J; Xie Y; Ding Z; Li F; Wang L
    J Appl Clin Med Phys; 2021 Jun; 22(6):146-153. PubMed ID: 33955134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films.
    Poder J; Corde S
    Med Phys; 2013 Dec; 40(12):121709. PubMed ID: 24320495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monte Carlo dosimetry of a new 192Ir pulsed dose rate brachytherapy source.
    Karaiskos P; Angelopoulos A; Pantelis E; Papagiannis P; Sakelliou L; Kouwenhoven E; Baltas D
    Med Phys; 2003 Jan; 30(1):9-16. PubMed ID: 12557972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2.
    Granero D; Vijande J; Ballester F; Rivard MJ
    Med Phys; 2011 Jan; 38(1):487-94. PubMed ID: 21361217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose calculation in brachytherapy for a 192Ir source using a primary and scatter dose separation technique.
    Russell KR; Ahnesjö A
    Phys Med Biol; 1996 Jun; 41(6):1007-24. PubMed ID: 8794481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of the absorbed dose distribution near an 192Ir intravascular brachytherapy seed using a high-spatial-resolution gel dosimetry system.
    Massillon-JL G; Minniti R; Mitch MG; Soares CG
    Phys Med Biol; 2012 Jun; 57(11):3407-18. PubMed ID: 22572625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monte Carlo characterization of the M-19 high dose rate Iridium-192 brachytherapy source.
    Medich DC; Munro JJ
    Med Phys; 2007 Jun; 34(6):1999-2006. PubMed ID: 17654903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of magnetic fields on calculated AAPM TG-43 parameters for
    Ranjbar S; Gholami S; Longo F; Sharp R; Meigooni AS
    Appl Radiat Isot; 2020 May; 159():109088. PubMed ID: 32250763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and characterization of a new high-dose-rate brachytherapy Valencia applicator for larger skin lesions.
    Candela-Juan C; Niatsetski Y; van der Laarse R; Granero D; Ballester F; Perez-Calatayud J; Vijande J
    Med Phys; 2016 Apr; 43(4):1639. PubMed ID: 27036563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phantom size in brachytherapy source dosimetric studies.
    Pérez-Calatayud J; Granero D; Ballester F
    Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.